TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+7.13%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$181M
AUM Growth
+$181M
(+12%)
Cap. Flow
+$1.19M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
71.78%
Holding
42
New
6
Increased
12
Reduced
7
Closed
4
Top Buys
| 1 |
NXTM
NxStage Medical Inc.
NXTM
|
$6.66M |
| 2 |
NovoCure
NVCR
|
$6.29M |
| 3 |
QuidelOrtho
QDEL
|
$5.2M |
| 4 |
Quest Diagnostics
DGX
|
$4.93M |
| 5 |
McKesson
MCK
|
$3.9M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$26.6M |
| 2 |
CVS Health
CVS
|
$6.1M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$4.17M |
| 4 |
Steris
STE
|
$3.94M |
| 5 |
Dentsply Sirona
XRAY
|
$2.99M |
Sector Composition
| 1 | Healthcare | 92.93% |
| 2 | Industrials | 3.28% |
| 3 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NovoCure
NVCR
$1.38B
| $21.3M | 11.63% | 1,055,000 +311,446 | +42% | +$6.29M |
|
|
MDRX
2
DELISTED
Veradigm Inc. Common Stock
MDRX
| $20M | 10.92% | 1,375,000 -100,000 | -7% | -$1.45M |
|
3
Pacira BioSciences
PCRX
$1.2B
| $14.4M | 7.85% | 315,000 +65,000 | +26% | +$2.97M |
|
4
Labcorp
LH
$23.1B
| $12.8M | 6.97% | 80,000 +20,000 | +33% | +$3.19M |
|
|
NUVA
5
DELISTED
NuVasive, Inc.
NUVA
| $12.3M | 6.72% | 210,340 +50,340 | +31% | +$2.94M |
|
6
Medtronic
MDT
$119B
| $12.1M | 6.61% | 150,000 -15,000 | -9% | -$1.21M |
|
|
7
QuidelOrtho
QDEL
$1.95B
| $11.7M | 6.39% | 270,000 +120,000 | +80% | +$5.2M |
|
|
CORI
8
DELISTED
Corium International, Inc.
CORI
| $9.71M | 5.3% | 1,010,000 +60,000 | +6% | +$577K |
|
9
Gilead Sciences
GILD
$140B
| $9.31M | 5.08% | 130,000 +5,000 | +4% | +$358K |
|
|
NXTM
10
DELISTED
NxStage Medical Inc.
NXTM
| $6.66M | 3.64% | +275,000 | New | +$6.66M |
|
|
11
Nektar Therapeutics
NKTR
$568M
| $6.27M | 3.42% | 105,000 -445,000 | -81% | -$26.6M |
|
|
12
Quest Diagnostics
DGX
$20.3B
| $4.93M | 2.69% | +50,000 | New | +$4.93M |
|
|
SRCL
13
DELISTED
Stericycle Inc
SRCL
| $4.19M | 2.29% | 61,641 -61,359 | -50% | -$4.17M |
|
|
HIND
14
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $3.99M | 2.18% | 604,036 +56,500 | +10% | +$373K |
|
|
15
McKesson
MCK
$85.4B
| $3.9M | 2.13% | +25,000 | New | +$3.9M |
|
16
Alkermes
ALKS
$4.78B
| $3.83M | 2.09% | +70,000 | New | +$3.83M |
|
17
Service Corp International
SCI
$11.1B
| $3.73M | 2.04% | +100,000 | New | +$3.73M |
|
18
AtriCure
ATRC
$1.84B
| $3.19M | 1.74% | 175,000 +75,000 | +75% | +$1.37M |
|
|
ADMS
19
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $3.14M | 1.71% | +92,600 | New | +$3.14M |
|
20
Lantheus
LNTH
$3.73B
| $3.08M | 1.68% | 150,437 +20,437 | +16% | +$418K |
|
|
CORV
21
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $2.91M | 1.59% | 1,875,000 +125,000 | +7% | +$194K |
|
|
ISEE
22
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.34M | 1.28% | 750,000 -25,000 | -3% | -$78K |
|
|
23
Steris
STE
$24.1B
| $2.19M | 1.19% | 25,000 -45,000 | -64% | -$3.94M |
|
|
STRM
24
DELISTED
Streamline Health Solutions
STRM
| $1.78M | 0.97% | 1,050,000 +3,334 | +0.3% | +$5.64K |
|
|
RCM
25
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.76M | 0.96% | 400,000 -25,000 | -6% | -$110K |
|